Peloton Therapeutics

2019’s Exits and Acquisitions Include Notable DFW Startups and Enterprises

by | Jan 15, 2020
A strong year of M&A activity made headlines for North Texas startups and enterprise companies in 2019.
Follow the Money: InterGen Data Raises $800K in Seed Funding, Nuvei Makes $889M Tech Acquisition
by | May 23, 2019
You’ll also find news about Actuate Therapeutics, Naturally Slim, AmeriTex, Peloton Therapeutics, Stream Energy, and The Crosby Group in this roundup of funding, merger, and acquisition activity involving companies in North Texas.
Dallas’ Peloton Therapeutics Exits to Merck in $2.2B Deal
by | May 22, 2019
The clinical-stage oncology company develops small molecule drugs to treat kidney cancer and other diseases. Its renal cell carcinoma drug is in a Phase II clinical trial.
DI People: Farmer Brothers, projekt202, BenefitMall Announce Leadership Moves
by | May 14, 2019
You’ll also find news from Fashion Industry Gallery; Sheppard, Mullin, Richter & Hampton LLP; Spence Diamonds; Thompson & Knight; Peloton Therapeutics; and Freese and Nichols in this roundup of leadership and executive moves by companies in North Texas.

Peloton Therapeutics Completes Series D Financing

by | Sep 19, 2016
Its drug therapy for advanced or metastatic clear cell kidney cancer is in phase 1 clinical trials at UT Southwestern.